Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Blood|September 7, 2006
Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survivalYasodha Natkunam, Eric D Hsi, Patricia Aoun, et al.Leukemia & Lymphoma|March 8, 2024
Lenalidomide, rituximab (R2), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphomaBrian T Hill, Yanwen Chen, Deepa Jagadeesh, et al.Leukemia & Lymphoma|September 15, 2021
The impact of socioeconomic disparities on the use of upfront autologous stem cell transplantation for mantle cell lymphomaYazeed Sawalha, Tomas Radivoyevitch, Xuefei Jia, et al.Hematology/Oncology and Stem Cell Therapy|October 20, 2019
Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeSagar S Patel, Lisa Rybicki, Brad Pohlman, et al.Leukemia & Lymphoma|July 16, 2010
Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remissionLisa Sproat, Brian Bolwell, Lisa Rybicki, et al.Clinical Lymphoma, Myeloma & Leukemia|August 6, 2017
Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General PopulationYazan F Madanat, Lisa Rybicki, Tomas Radivoyevitch, et al.Leukemia & Lymphoma|July 12, 2017
A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphomaBrian T Hill, Mitchell R Smith, Meredeth Shelley, et al.Journal of Clinical Apheresis|August 6, 2019
Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantationJack Khouri, Lisa Rybicki, Navneet S Majhail, et al.Therapeutic Advances in Hematology|April 7, 2018
Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplantJoshua Allen, Ana Lucia Ruano Mendez, Lisa Rybicki, et al.Clinical Lymphoma, Myeloma & Leukemia|August 10, 2017
Grade 3 Follicular Lymphoma: Outcomes in the Rituximab EraMoaath Mustafa Ali, Lisa Rybicki, Laila Nomani, et al.Pageof 8